相似文献
1
Corticosteroids in COVID-19: one size does not fit all.
Eur Respir J. 2021 Apr 15;57(4). doi: 10.1183/13993003.00224-2021. Print 2021 Apr.
2
Corticosteroids May Be Indicated in Children with Severe COVID-19 Disease.
Pediatr Ann. 2021 Jul;50(7):e270-e271. doi: 10.3928/19382359-20210701-01. Epub 2021 Jul 1.
3
Reply: Corticosteroids May Be Indicated in Children with Severe COVID-19 Disease.
Pediatr Ann. 2021 Jul;50(7):e271. doi: 10.3928/19382359-20210520-01. Epub 2021 Jul 1.
4
The Uncertain Role of Corticosteroids in the Treatment of COVID-19-Reply.
JAMA Intern Med. 2021 Jan 1;181(1):140-141. doi: 10.1001/jamainternmed.2020.2435.
5
Therapeutic Application of Corticosteroids in COVID-19: A Focus on Optimum Dose and Duration of Therapy.
J Clin Pharmacol. 2021 Sep;61(9):1145-1148. doi: 10.1002/jcph.1929. Epub 2021 Jul 10.
6
Early, low-dose, short-term methylprednisolone decreased the mortality in critical COVID-19 patients: A multicenter retrospective cohort study.
J Infect. 2021 Apr;82(4):84-123. doi: 10.1016/j.jinf.2020.11.001. Epub 2020 Nov 8.
7
Methylprednisolone therapy induces differential metabolic trajectories in severe COVID-19 patients.
mSystems. 2023 Dec 21;8(6):e0072623. doi: 10.1128/msystems.00726-23. Epub 2023 Oct 24.
8
Corticosteroid Protection Against COVID-19: Begin with the Nose.
J Allergy Clin Immunol Pract. 2021 Nov;9(11):3941-3943. doi: 10.1016/j.jaip.2021.08.025. Epub 2021 Sep 17.
9
Corticosteroids in patients with COVID-19: use and misuse.
Minerva Anestesiol. 2021 Sep;87(9):1042-1048. doi: 10.23736/S0375-9393.21.15625-1. Epub 2021 Jun 8.
10
Are intravenous corticosteroid pulses superior to low dose corticosteroids in patients with severe COVID-19?
Eur Respir J. 2022 Oct 20;60(4). doi: 10.1183/13993003.01220-2022. Print 2022 Oct.
引用本文的文献
1
A Retrospective Data Audit of Outcome of Moderate and Severe Covid-19 Patients Who Had Received MP and Dex: A Single Center Study.
Infect Drug Resist. 2024 Dec 9;17:5491-5505. doi: 10.2147/IDR.S418788. eCollection 2024.
2
Efficacy and safety of glucocorticoids in the treatment of COVID-19: a systematic review and meta-analysis of RCTs.
Clin Exp Med. 2024 Jul 13;24(1):157. doi: 10.1007/s10238-024-01405-0.
3
The Relationship between COVID-19 and Hypothalamic-Pituitary-Adrenal Axis: A Large Spectrum from Glucocorticoid Insufficiency to Excess-The CAPISCO International Expert Panel.
Int J Mol Sci. 2022 Jun 30;23(13):7326. doi: 10.3390/ijms23137326.
4
Severity-Adjusted Dexamethasone Dosing and Tocilizumab Combination for Severe COVID-19.
Yonsei Med J. 2022 May;63(5):430-439. doi: 10.3349/ymj.2022.63.5.430.
5
Personalized therapy: can it tame the COVID-19 monster?
Per Med. 2021 Sep;18(6):583-593. doi: 10.2217/pme-2021-0077. Epub 2021 Oct 15.
6
Tocilizumab administration for the treatment of hospitalized patients with COVID-19: A systematic review and meta-analysis.
Respirology. 2021 Nov;26(11):1027-1040. doi: 10.1111/resp.14152. Epub 2021 Oct 3.
7
A Multidisciplinary Approach to Coronavirus Disease (COVID-19).
Molecules. 2021 Jun 9;26(12):3526. doi: 10.3390/molecules26123526.
8
Dexamethasone in the Treatment of COVID-19: Primus Inter Pares?
J Pers Med. 2021 Jun 15;11(6):556. doi: 10.3390/jpm11060556.
9
Steroid use in elderly critically ill COVID-19 patients.
Eur Respir J. 2021 Oct 7;58(4). doi: 10.1183/13993003.00979-2021. Print 2021 Oct.
Zotero 插件